Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2020

01-08-2020 | Multiple Myeloma | Images in Hematology

Testicular plasmacytoma in a patient with relapsed multiple myeloma

Authors: Dimitrios Pilalas, Christos Savopoulos, Ioannis Vakalopoulos, Dimosthenis Miliaras, Anastasios Lefkopoulos, Georgia D. Kaiafa

Published in: International Journal of Hematology | Issue 2/2020

Login to get access

Excerpt

A 70-year-old male patient presented acute onset unilateral scrotal swelling and tenderness. The patient received a presumptive diagnosis of epididymo-orchitis and treatment with ciprofloxacin and supportive care was initiated by his treating urologist. Nevertheless, the symptoms did not subside and color Doppler ultrasonography was conducted: a solid hyperechoic lesion (7 cm × 5 cm) with increased vascularity was documented in the left testicle along with a mild enlargement and increased vascularity of the adjacent epididymis. …
Literature
1.
Gigantino V, La Mantia E, Franco R, Cecere S, Rossetti S, Di Napoli M, et al. Testicular and testicular adnexa tumors in the elderly. Anticancer Drugs. 2013;24:228–36.CrossRef
2.
Metadata
Title
Testicular plasmacytoma in a patient with relapsed multiple myeloma
Authors
Dimitrios Pilalas
Christos Savopoulos
Ioannis Vakalopoulos
Dimosthenis Miliaras
Anastasios Lefkopoulos
Georgia D. Kaiafa
Publication date
01-08-2020
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 2/2020
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-02902-0

Other articles of this Issue 2/2020

International Journal of Hematology 2/2020 Go to the issue

Letter to the Editor

Effect of age and comorbidities on the decline of glomerular filtration rate in chronic myeloid leukemia patients discontinuing tyrosine kinase inhibitors

Original Article

Functional characterization of a germline ETV6 variant associated with inherited thrombocytopenia, acute lymphoblastic leukemia, and salivary gland carcinoma in childhood

Original Article

T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

Images in Hematology

Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22)

Review Article

The human spleen as the center of the blood defense system

Original Article

The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits